Possible toxic effects of normal and diabetic patient serum on pancreatic B-cells

22Citations
Citations of this article
124Readers
Mendeley users who have this article in their library.

Abstract

Serum from normal blood-donors and juvenile diabetic patients inhibited Rb+ accumulation and stimulated release of 51Cr and insulin in suspensions of dispersed pancreatic islet cells prepared from ob/ob mouse islets, which are rich in B-cells. The effects indicate the presence of a B-cytotoxic factor in human serum. Serum from mouse and fetal calf also inhibited the islet cell accumulation of Rb+. Toxicity was not suppressed by treating serum with protein A-Sepharose and did not correlate with islet cell binding of fluorescent antibodies to human immunoglobulin. Whereas all sera inhibited Rb+ accumulation, 3 of 6 diabetic patient sera, but no blood-donor serum, made the cells fluoresce on exposure to the fluorescent antibodies. Supporting a dependence on complement, toxicity remained after dialysis, but was destroyed by treating serum with zymosan-A or heating at 56 ° for 30 min. © 1978 Springer-Verlag.

Cite

CITATION STYLE

APA

Lernmark, A., Sehlin, J., Täljedal, I. B., Kromann, H., & Nerup, J. (1978). Possible toxic effects of normal and diabetic patient serum on pancreatic B-cells. Diabetologia, 14(1), 25–31. https://doi.org/10.1007/BF00429704

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free